153 related articles for article (PubMed ID: 31377904)
1. Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer.
Volkov NM; Yanus GA; Ivantsov AO; Moiseenko FV; Matorina OG; Bizin IV; Moiseyenko VM; Imyanitov EN
Invest New Drugs; 2020 Jun; 38(3):894-898. PubMed ID: 31377904
[TBL] [Abstract][Full Text] [Related]
2. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
Picard E; Verschoor CP; Ma GW; Pawelec G
Front Immunol; 2020; 11():369. PubMed ID: 32210966
[TBL] [Abstract][Full Text] [Related]
3. Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.
Elsaid A; Elshazli R; El-Tarapely F; Darwish H; Abdel-Malak C
Fam Cancer; 2017 Jan; 16(1):83-90. PubMed ID: 27631816
[TBL] [Abstract][Full Text] [Related]
4. Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.
Pitroski CE; Cossio SL; Koehler-Santos P; Graudenz M; Prolla JC; Ashton-Prolla P
Int J Colorectal Dis; 2011 Jul; 26(7):841-6. PubMed ID: 21424714
[TBL] [Abstract][Full Text] [Related]
5. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas.
Nielsen M; de Miranda NF; van Puijenbroek M; Jordanova ES; Middeldorp A; van Wezel T; van Eijk R; Tops CM; Vasen HF; Hes FJ; Morreau H
BMC Cancer; 2009 Jun; 9():184. PubMed ID: 19527492
[TBL] [Abstract][Full Text] [Related]
6. MUTYH hotspot mutations in unselected colonoscopy patients.
Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies.
Yanus GA; Akhapkina TA; Ivantsov AO; Preobrazhenskaya EV; Aleksakhina SN; Bizin IV; Sokolenko AP; Mitiushkina NV; Kuligina ES; Suspitsin EN; Venina AR; Holmatov MM; Zaitseva OA; Yatsuk OS; Pashkov DV; Belyaev AM; Togo AV; Imyanitov EN; Iyevleva AG
Clin Genet; 2018 May; 93(5):1015-1021. PubMed ID: 29406563
[TBL] [Abstract][Full Text] [Related]
9. A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.
Viel A; Bruselles A; Meccia E; Fornasarig M; Quaia M; Canzonieri V; Policicchio E; Urso ED; Agostini M; Genuardi M; Lucci-Cordisco E; Venesio T; Martayan A; Diodoro MG; Sanchez-Mete L; Stigliano V; Mazzei F; Grasso F; Giuliani A; Baiocchi M; Maestro R; Giannini G; Tartaglia M; Alexandrov LB; Bignami M
EBioMedicine; 2017 Jun; 20():39-49. PubMed ID: 28551381
[TBL] [Abstract][Full Text] [Related]
10. Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.
Rosner G; Bercovich D; Daniel YE; Strul H; Fliss-Isakov N; Ben-Yehoiada M; Santo E; Halpern Z; Kariv R
Fam Cancer; 2015 Sep; 14(3):427-36. PubMed ID: 25822476
[TBL] [Abstract][Full Text] [Related]
11. Common MUTYH mutations and colorectal cancer risk in multiethnic populations.
Lejbkowicz F; Cohen I; Barnett-Griness O; Pinchev M; Poynter J; Gruber SB; Rennert G
Fam Cancer; 2012 Sep; 11(3):329-35. PubMed ID: 22371070
[TBL] [Abstract][Full Text] [Related]
12. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
14. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.
Nielsen M; Joerink-van de Beld MC; Jones N; Vogt S; Tops CM; Vasen HF; Sampson JR; Aretz S; Hes FJ
Gastroenterology; 2009 Feb; 136(2):471-6. PubMed ID: 19032956
[TBL] [Abstract][Full Text] [Related]
15. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
16. Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers.
de Miranda NF; Hes FJ; van Wezel T; Morreau H
Mutagenesis; 2012 Mar; 27(2):247-53. PubMed ID: 22294774
[TBL] [Abstract][Full Text] [Related]
17. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
18. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer.
Kuno T; Matsubara N; Tsuda S; Kobayashi M; Hamanaka M; Yamagishi D; Tsukamoto K; Yamano T; Noda M; Ikeuchi H; Kim S; Tamura K; Tomita N
Oncol Rep; 2012 Aug; 28(2):473-80. PubMed ID: 22641385
[TBL] [Abstract][Full Text] [Related]
20. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
